Products and Resources Catalog

This webinar, presented on December 19, 2018 by Mary Hatch-Maillette, PhD, described how and why SUD treatment counselors should strive for greater comfort and ease in talking to patients about their sexual risk behavior. This includes how counselors can improve their own skill and comfort, a description of the MI Spirit approach, and how they can better link sexual risk with substance use, treatment and recovery when talking with their patients. About the presenter: Mary Hatch-Maillette, PhD, is the co-director of the NIDA Clinical Trials Network's Pacific Northwest Node, and a researcher at the University of Washington Addictions, Drug & Alcohol Institute. She specializes in substance use treatment, HIV risk behavior, and counselor workforce issues. She is also in private psychotherapy practice in Seattle. Download slides | Watch recording  

This document provides important facts about HCV and offers comprehensive information on the HCV Current initiative.

This publication assists behavioral health professionals who treat people with substance abuse problems in understanding the implications of a diagnosis of hepatitis. It also discusses screening, diagnosis, and referrals and explains how to evaluate a program's hepatitis practices.

Our nation's battle plan for fighting viral hepatitis in the United States. The updated plan outlines strategies to achieve four major goals and includes indicators to help track progress between now and 2020. The goals are: Goal 1: Prevent new viral hepatitis infections Goal 2: Reduce deaths and improve the health of people living with viral hepatitis Goal 3: Reduce viral hepatitis health disparities Goal 4: Coordinate, monitor, and report on implementation of viral hepatitis activities

This list is prepared by the Division of Viral Hepatitis and the National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention. It contains the state/city, the Program Manager Coordinator, e-mail address, phone number and website.

This presentation by Professor Katherine Sorsdahl discusses the Screening, Brief Intervention, and Referral to Treatment (SBIRT) training model with applications in the South African context. Katherine Sorsdahl is a Professor and the Co-Director of the Alan J Flisher Centre for Public Mental Health at the University of Cape Town. She also serves as Expert Curriculum Development Advisor for the South Africa HIV ATTC.

This presentation by Professor Bronwyn Myers discusses the Screening, Brief Intervention, and Referral to Treatment (SBIRT) training model in application to substance use disorders. Professor Bronwyn Myers is a Chief specialist scientist in the Alcohol Tobacco and Other Drug Use Research Unit at the South African Medical Research Council. Professor Myers also serves as an Expert Technical Assistance Advisor for the South Africa HIV ATTC.

Monthly electronic newsletter

Presenter Harold Gates offers best practices for sustaining professional and organizational commitments to cultural competence and effective application of CLAS.

Dr. Ryan Westergaard specializes in infectious disease and substance use disorder treatment. In this webinar, he provides an overview of the intersection between injection drug use, opioid use disorders, and HIV and viral hepatitis infections.

Monthly electronic newsletter highlighting Great Lakes ATTC training events and other topics.

Monthly electronic newsletter featuring Great Lakes ATTC training events and other topics.

Mid-America ATTC has developed a 2018 version of the Hepatitis Awareness Month (May) Info Sheet and Bulletin Insert. Side one has been updated to focus on the dual epidemics of the opioid crisis and hepatitis C virus (HCV). Although the document was initially designed for the faith community, it is appropriate as an educational flyer for much broader audiences. This product can be easily downloaded and used by churches, temples and mosques for their Sunday/Sabbath-day bulletins, newsletter

Learn through example by watching any or all of six vignettes which illustrate how, through MI, practitioners can help their patients develop intrinsic motivation to be tested for HCV and to feel positive about making a responsible health decision. Each unique scenario features a trained motivational interviewer speaking with a patient at risk for hepatitis C. The videos portray a diverse group of backgrounds and life experiences.

This 90-minute, self-paced course is designed to briefly familiarize medical and behavioral health professionals with hepatitis C virus (HCV), specifically: 1) populations at risk; 2) hepatitis C, the disease; 3) screening processes; and 4) treatment options.

This presentation discussed challenges and opportunities working with adolescents with substance use disorders, with a focus on continuity of care. Presented by Yifrah Kaminer, M.D.

This presentation described: (1) the epidemics of HIV and HCV among US adolescents and young adults with regional examples. (2) the HIV continuum of care for Adolescents and Young Adults. (3) the value of HIV treatment, and current antiretroviral treatment guidelines and recent updates in care and treatment (4) how to incorporate HIV and HCV prevention, screening and linkage to care into your work with youth. Presented by Cathryn Samples, M.D.

Expert presenter bios at the 2015 Improving Care for Substance Use, HIV and/or HCV in Adolescents: Effective Approaches for Assessing, Treating, and Engaging Teens